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Association between adiposity 
indicators, metabolic parameters 
and inflammatory markers in a 
sample of female adolescents
Priscilla Rizental Coutinho1, Neiva Leite2, Wendell Arthur Lopes3,4, Larissa Rosa 
da Silva2, Cássio M. Consentino2, Cristiane T. Araújo2, Frederico B. Moraes Jr.2, 
Incare C. de Jesus2, Cláudia Regina Cavaglieri3, Rosana Bento Radominski1,5 
ABSTRACT
Objective: The aim of this study was to investigate the association between total and abdominal adi-
posity with metabolic parameters and inflammatory markers, in female adolescents. Subjects and 
methods: The sample consisted of 53 adolescents aged 13 to 17 years from a public school in Curi-
tiba, Brazil. The adiposity indicators studied were body mass index (BMI), waist circumference (WC), 
trunk fat mass (TKFM), total fat mass (TFM) and body fat percentage (BF%) measured by dual-energy 
X-ray absorptiometry. The metabolic and inflammatory parameters studied were systolic blood pres-
sure (SBP), diastolic blood pressure (DBP), glucose, insulin, homeostasis model assessment index 
for insulin resistance (HOMA-IR), lipids, C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis 
factor alpha (TNF-α), leptin, adiponectin and resistin. Results: Eighty percent of WC variation, 87% 
of TKFM and TFM, and 73% of BF% were predicted by BMI variation. There was a significant positive 
correlation between all indicators of adiposity with SBP, DBP, insulin, HOMA-IR, CRP and leptin. Tri-
glycerides were positively correlated with BMI and WC, and adiponectin correlated negatively with 
BMI. TNF-α, IL-6, glucose, total cholesterol, and high- and low-density lipoprotein cholesterol did not 
correlate to the studied variables. Conclusion: BMI showed a significant association with most of the 
parameters studied, and WC was slightly better than BMI to predict insulin resistance in this specific 
population. Arch Endocrinol Metab. 2015;59(4):325-34
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O besity in children and adolescents has increased significantly in recent decades, resulting in the 
development of chronic diseases and metabolic syn-
drome during adulthood (1). Abdominal or central 
adiposity is a risk factor for diabetes and cardiovascular 
disease in adults, regardless of the degree of obesity. In 
children and adolescents, the impact of body fat distri-
bution in obesity complications is uncertain (2).
Obesity induces adipocyte dysfunction, with se-
cretion of adipokines and macrophage activation 
leading to inflammatory cytokine production, which 
results in a cascade of reactions that influence meta-
bolic parameters, atherogenic processes and insulin 
sensitivity (3).
Body mass index (BMI) is used for the diagnosis 
of obesity in adolescents, although it does not assess 
the distribution of body fat (4). Studies have suggested 
that the evaluation of waist circumference (WC) would 
better detect cardiovascular risk, metabolic disorders 
and insulin resistance in youth (5). However, other re-
searchers have reported divergent results (6) and, to 
date, there is no consensus on the usefulness of central 
obesity indicators as tools for detecting cardiometabol-
ic risk factors in adolescents.
Computed tomography and magnetic resonance 
imaging are the gold standard methods in assessing the 
distribution of abdominal fat, but its high cost and ra-
diation are limiting factors. For body composition anal-
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simple and low-risk method that evaluates the regional 
and total fat distribution with very good correlation 
with other radiological exams (7).
The aim of this study was to evaluate, in a sample of 
female adolescents, the association of different indica-
tors of adiposity with metabolic parameters and inflam-
matory markers, and to elucidate which adiposity mea-
sures identify individuals at risk of obesity complications.
SUBJECTS AND METHODS
Subjects
This study is cross-sectional and comprised of ado-
lescent girls, aged 13 to 17 years, from the 8th grade 
of elementary school to the 3th grade of high school, 
who studied in a public school in the city of Curitiba/
Paraná. The volunteers were recruited from April to 
October 2013 and were part of a previous longitudi-
nal study. The girls should be in the final stages of pu-
berty, to be included in the study (Tanner stages IV 
and V) (8). The exclusion criteria were the presence of 
chronic diseases, such as diabetes, non-controlled hy-
pothyroidism, endocrine diseases, infection and/or the 
use of medications that promoted changes in adiposity, 
metabolic or inflammatory parameters. The exclusion 
criteria were based on clinical history and, in uncertain 
cases, complementary exams were performed.
The volunteers underwent a medical consultation 
with complete anamneses and physical examinations, 
which included anthropometric measurements, check-
ing vital data and sexual maturation analysis as pro-
posed by Tanner (8). All tests were carried out with a 
maximal interval of one week between them.
Body composition and anthropometry 
Weight was measured with the subjects standing and 
wearing light clothes and barefoot, using a calibrated 
mechanical anthropometric scale (Filizola, São Paulo, 
Brazil), with precision of 0.1 kg and maximum capacity of 
150 kg. Height was measured by a wall-mounted stadi-
ometer (Tonelli, Criciúma, Brazil), with variation of 0.1 
cm to 220 cm range. BMI was calculated as weight di-
vided by height squared (kg/cm²). BMI z-score was cal-
culated and classified according to criteria defined by the 
World Health Organization for sex and age (9). Taking 
into consideration the BMI curve for their ages, subjects 
were considered: eutrophic, when BMI was between the 
score ≥ z −2 and < z +1; overweight, when BMI was 
between score ≥ z +1 and < z +2; and obese when BMI 
was ≥ z +2.
WC was measured midpoint between the last ribs 
and the iliac crests with an inelastic measuring tape with 
precision of 0.1 cm, and with the participant having 
overnight fasted and in a standing position (10). The 
measurement was performed in triplicate by a single 
trained professional. The average of the three measure-
ments was calculated and converted to z-scores adjust-
ed for age, according to data from the National Health 
and Nutrition Examination Surveys (11).
Body composition was assessed by Lunar Prodigy 
Primo DXA (GE Medical Systems Lunar, Madison, Wis-
consin, USA). The examinations were performed by a 
single trained professional, with intraobserver coefficient 
of variation of 0.1% for total mass, 2.4% for total fat mass 
(TFM), 3.06% for trunk fat mass (TKFM) and 1.64% for 
body fat percentage (BF%).The subjects wore appropri-
ate clothing, with no metal parts. Body composition was 
obtained with subjects in supine position on the exam 
table. Scanning was carried out from the upper cranial 
region to the ankle region. TFM and TKFM were de-
termined with approximation to 1 g and are described in 
kg. BF% was determined by TFM/total body mass ratio. 
TKFM was measured in the area bordered by a horizon-
tal line below the chin, vertical lines lateral to the ribs, 
and oblique lines passing through the femoral necks. For 
the reconstruction of the image of subjacent tissues and 
quantification of bone mineral content, TFM and free-fat 
mass, the enCORE 2008 (version 12.30) software (GE 
Medical Systems, Madison, Wisconsin, USA) was used.
Blood pressure and laboratory analysis 
Blood pressure was measured by a calibrated sphygmo-
manometer (BD, Germany) with the subject seated after 
five minutes of rest. The measurement was carried out 
on the left upper arm, and the cuff was selected in order 
to cover two-thirds of the arm perimeter. The presence 
of sound in the brachial artery was used to identify the 
systolic blood pressure (SBP), and its disappearance was 
used to identify the diastolic blood pressure (DBP). Af-
ter the first measurement, the air of the cuff was totally 
released and, after two minutes, a new measurement was 
carried out. The average of the two measurements was 
obtained and converted into z-score for height and age, 
according to guidelines of The Fourth Report on the 
Diagnosis, Evaluation and Treatment of High Blood 
Pressure in Children and Adolescents of the National 
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Serum and plasma blood samples (20 mL) were 
obtained from the antecubital vein and collected into 
vacutainer tubes containing EDTA anticoagulant (Bec-
ton Dickinson Ltd., Oxford, UK) by a trained phle-
botomist. The samples were collected in the morning 
(07:00–09:00) after a 12-h overnight fast. All samples 
were collected, processed, divided into serum or plasma 
aliquots and stored at −80 °C for subsequent analysis. 
Serum samples were used for inflammatory and lipids 
analysis and plasma samples were used for insulin and 
glucose analysis. 
Total cholesterol, triglycerides and high-density lipo-
protein (HDL) levels were analyzed using a commercial 
kit. Low-density lipoprotein (LDL) was calculated us-
ing the Friedewald equation (13). Blood glucose levels 
were determined by the enzymatic method and insulin 
was measured by the chemiluminescence immunoassay 
technique by automated equipment. Insulin resistance 
was estimated by the homeostasis model assessment 
(HOMA-IR) described by Matthews and cols. (14). 
Serum concentrations of C-reactive protein (CRP), 
tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-
6), resistin, leptin and adiponectin were determined by 
enzyme-linked immunosorbent assay (ELISA), follow-
ing the specifications of the manufacturer (Quantikine 
High Sensitivity Kit, R&D Systems, Minneapolis, MN, 
USA). The intra-assay and inter-assay coefficients and 
sensitivity were as follows: 7.4%, 6.5% and 0.039 pg/
mL for IL-6; 3.1%, 7.2% and 0.106 pg/mL for TNF-α; 
3.8%, 6.0% and 0.010 ng/mL for CRP; 3.0%, 3.5% and 
7.8 pg/mL for leptin; 2.8%, 5.9% and 0.246 ng/mL for 
adiponectin; 3.8%, 7.8% and 0.026 ng/mL for resistin.
Assessment of adiposity and metabolic parameters
The indicators of total adiposity considered in this study 
were BMI, TFM (kg) and BF% and the indicators of cen-
tral adiposity were WC and TKFM. The metabolic pa-
rameters included in the analyzes were SBP, DBP, total 
cholesterol, HDL, LDL, triglycerides, glucose, insulin 
and HOMA-IR, and the inflammatory parameters were 
CRP, IL-6, TNF-α, leptin, resistin and adiponectin. 
This research was approved by the Ethics Commit-
tee of the Clinical Hospital of the Federal University of 
Parana (Protocol number 2460.067/2011).
Statistical analysis 
The data are presented as means and standard devia-
tion or median and interquartile range, according to 
the normality assumption assessed by the Shapiro–Wilk 
test. The variables DBP, insulin, HOMA-IR, triglycer-
ides, CRP, TNF-α, IL-6, leptin, resistin and adiponec-
tin were transformed into logarithms for linear regres-
sion analysis, as they do not have a normal distribution. 
Pearson correlation and multiple linear regression were 
used for the analysis of central and total obesity indi-
cators in relation to the studied variables. Data were 
analyzed using IBM SPSS Statistics for Windows, Ver-
sion 19.0. (Armonk, NY: IBM Corp.), with p ≤ 0.05 
considered significant.
RESULTS
Of the 341 recruited girls, 55 volunteered of which 53 
met the inclusion criteria with two teenagers excluded 
owing to pubertal stage. Mean age, weight and height 
were 14.66 ± 1.10 years, 70.24 ± 14.23 kg and 162.40 
± 5.70 cm, respectively. Twenty-one girls were obese 
(39.6%), 17 overweight (32.1%) and 15 were normal 
weight (28.3%). The characteristics of the study popu-
lation are shown in table 1.
Table 1. Characteristics of the study participants
Parameter n = 53 Minimum Maximum
BMI-z 1.7 (0.6-2.3)b -0.7 3.0
WC-z 0.2 ± 0.8a -1.4 2.2
TFM (kg) 28.6 ± 10.0a 12.3 52.9
TKFM (kg) 14.0 ± 5.6a 5.2 27.3
BF% 39.8 ± 7.1a 23.8 56.0
SBP-z 0.78 ± 9.7a -2.9 1.0
DBP-z -1.17± 0.7a -1.5 2.2
Glucose (mg/dL) 87.4 ± 8.1a 70.8 111.0
Insulin (mU/mL) 12.0 (9.9-18.7)b 5.2 60.6
HOMA-IR 2.5 (2.0-4.1)b 1.0 13.9
Total cholesterol (mg/dL) 160.8 ± 29.2a 100.3 217.4
HDL (mg/dL) 57.3 ± 10.7a 35.5 89.8
LDL (mg/dL) 82.8 ± 21.8a 43.9 141.5
TG (mg/dL) 83.9 (70.0-120.2)b 41.0 403.7
CRP (ng/mL) 1.4 (0.5-4.7)b 0.0 11.0
TNF-α (pg/mL) 1.7 (1.2-2.4)b 0.6 14.8
IL-6 (pg/mL) 1.2 (0.9-2.0)b 0.5 8.5
Resistin (ng/mL) 6.7 (5.2-8.7)b 2.4 19.0
Adiponectin (ng/mL) 5.8 (4.9-9.3)b 0.8 26.1
Leptin (pg/mL) 40.4 (25.9-59.5)b 8.6 104.4
a: Data in means ± standard deviation. b: Data in median and inter-quartile range.
BF%: body fat percentage; BMI-z: body mass index z-score; DBP-z: diastolic blood pressure 
z-score; HDL: HDL cholesterol; LDL: LDL cholesterol; SBP-z: sistolic blood pressure z-score; 
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Adiposity indicators
There was a significant positive correlation between all 
the adiposity indicators studied. TFM was strongly as-
sociated with BMI (r = 0.934) and BF% (r = 0.854), 
and TKFM showed excellent correlation with WC (r = 
0.912), demonstrating that the anthropometric mea-
sures were strongly related according to the gold stan-
dard measurements obtained by DXA (data not avail-
able in table).
Approximately 80% of the variation in WC, 87% of 
both TKFM and TFM, and 73% of the BF% could be 
predicted by the variation in BMI (Figure 1). The WC 
varied 83% depending on the TKFM, 80% as a function 
of TFM and 60% in relation to BF% (Figure 2).
Metabolic parameters 
All adiposity indicators demonstrated a significant posi-
tive association with SBP, DBP, insulin and HOMA-IR 
index. Twenty-three percent of the SBP variation was 
explained by TFM, followed by BF%, TKFM and BMI. 
The explanatory power of these indicators was similar 
and higher than with the WC. Twenty-seven percent of 
DBP variation was due to TFM, followed by BMI, WC 
and TKFM with almost identical associations (Table 2).
For insulin values and HOMA-IR index, a greater ef-
fect can be observed with WC (38% for both) compared 
with BMI (34% and 33%, respectively) and other measures 
of adiposity. The WC sensitivity for detection of girls with 
HOMA-IR ≥ 2.70 was 88% with a specificity of 60.7%, and 
for BMI the sensitivity was 76% and specificity of 71.4%.
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Glucose, total cholesterol, HDL and LDL were not 
associated with the adiposity indicators studied. Tri-
glycerides varied according to the BMI and WC simi-
larly.
Inflammatory markers
All adiposity indicators demonstrated a significant 
positive association with the CRP and leptin levels. 
The CRP was mostly influenced by the BF%, TFM and 
WC, and leptin varied 61% based on BMI and TFM. 
Resistin correlated positively only with the BF%, and 
adiponectin correlated negatively with BMI. IL-6 and 
TNF-α were not associated with the adiposity indica-
tors studied.
Table 2. Linear regression coeficients (β) e r2 for central and total adiposity measures with metabolic parameters






























































































































































































* p < 0.05; ** p < 0.01.  
BF%: body fat percentage; BMI-z: body mass index z-score; DBP-z: diastolic blood pressure z-score; HDL: HDL cholesterol; HOMA-IR: Homeostasis Model Assessment; LDL: LDL cholesterol; SBP-z: 
sistolic blood pressure z-score; TC: total cholesterol; TFM: total fat mass; TG: triglycerides; TKFM: trunk fat mass. WC-z: waist circumference z-score.
Metabolic parameters and inflammatory markers
When analyzing inflammatory markers in relation to 
metabolic parameters, we observed an association of 
CRP to insulin and to HOMA-IR index, and also of 
leptin with SBP, DBP, insulin and HOMA-IR. Adipo-
nectin was inversely correlated with blood glucose, in-
sulin, HOMA-IR and triglycerides and TNF-α showed 
a negative association with HDL (Table 3).
DISCUSSION
Excess weight can begin in childhood and researchers 
have discussed how to identify, in this age group, those 
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Some authors argue that the pattern of distribution of 
fat, especially abdominal fat, would be effective in pre-
dicting risk (15). However, the data for children and 
adolescents are not clear and there are no established 
cutoff points for the pediatric population. BMI, despite 
its limitations on assessment of body fat distribution 
and the distinction between lean mass and fat mass, 
is an indicator of adiposity validated for the pediatric 
population (16). Given the controversy regarding the 
different methods of assessing adiposity in children and 
adolescents and their clinical implications, more studies 
are needed to identify the applicability of these param-
eters in this specific population.
In this study, adiposity measurements were strongly 
correlated with each other, and adolescents with higher 
BMI also presented higher WC, TKFM, TFM and BF% 
values, indicating that in the population analyzed, BMI 
properly identified adiposity. Studies evaluating the 
distribution of fat in adolescents, with similar results 
of this study, found a strong association between BMI 
and WC (r = 0.88–0.91) (17,18) and between TFM 
and BMI (r = 0.84–0.97) (19,20). Especially in girls, 
BMI has been a good indicator of adiposity, because 
in females a greater fat deposition occurs during the 
pubertal period (21).
In the present study, both BMI and WC explain 
similar variations in TKFM, demonstrating that these 
two anthropometric parameters shared similar influence 
in the estimation of abdominal adiposity. WC measure-
ment seems to be a reflection of the total adiposity in 
this population, which is different from that observed 
in adults. Its measure would bring no further informa-
tion, since BMI and WC assess the same thing in this 
particular group.
The relationship between direct and indirect mea-
sures of central and total body fat has been widely dis-
cussed. The Avon Longitudinal Study of Parents and 
Children (ALSPAC) demonstrated strong and stable 
correlation between BMI and WC in children aged 9 to 
11 years (r = 0.91 to 0.92), with attenuation at 13 (r = 
0.88) and 15 years of age (r = 0.84). The same pattern 
has been observed with TKFM and TFM measured by 
DXA (22). Perhaps these results indicate that with in-
creasing age there is a reduction of the influence of BMI 
on central adiposity, but the question is to know at what 
age the abdominal fat will became clinically important.
The blood pressure levels have had similar correla-
tion with all the adiposity indicators, showing that any 
of them can indicate individuals at risk for hyperten-
sion. Some authors suggested that blood pressure ap-
pears to be more dependent on total body fat rather 
than fat distribution in this age group. Adolescents 
and children with higher levels of blood pressure, even 
within normal limits, tend to progress over a lifetime 
showing higher incidence of hypertension in adulthood 
(23-25). A national study of 1716 volunteers aged 
10–16 years has shown that obesity detected by BMI, 
adjusted for sex, age and skin color increased by 27% 
the chance of a teenager presenting with hypertension; 
WC, despite its association with blood pressure, lost its 
effect after adjustment for BMI (26).
In this study, WC showed a close association with 
insulin levels, HOMA-IR and triglycerides, with mini-
mal difference in relation to BMI. These two indica-
tors, WC and BMI, were better than the measure of 
adiposity by DXA for these parameters. Possibly the 
highest concentration of intra-abdominal fat, responsi-
ble for such changes, is best assessed by measuring WC.
Table 3. Correlations between metabolic parameters and inflammatory markers
CRP IL-6 TNF-α Resistin Leptin Adiponectin
SBP 0.128 -0.039 0.052  0.266 0.296* -0.148
DBP 0.056 -0.044 0.085 0.022 0.379* -0.140
Glucose 0.139 -0.117 -0.092 -0.153 0.053 -0.292*
Insulin 0.317* 0.091 0.162 -0.156 0.387** -0.362**
HOMA-IR 0.326* 0.076 0.118 -0.183 0.358** -0.377**
TC 0.114 -0.133 -0.006 -0.020  0.206 0.046
HDL 0.108 -0.089 -0.279*  0.010 0.051 0.257
LDL -0.014 -0.130  0.081  0.060 0.142 0.122
TG 0.131 0.000 0.063 -0.197 0.179 -0.281*
Pearson’s correlation * p < 0.05; ** p < 0.01. 
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Previous studies have shown that WC is a strong 
predictor of insulin resistance in adolescents, regard-
less of BMI, BF% and TFM (27-29). However, in most 
of these studies, the samples were small and the age 
groups varied considerably (8–17 years) making it dif-
ficult to understand any real association or reflection of 
change in body composition.
Blüher and cols. (30) in a prospective study that 
evaluated the correlation between BMI, WC and TFM, 
as measured by DXA, for cardiovascular risk factors in 
5235 children aged 9–12 years and 15 and 16 years, 
found a greater association of BMI with insulin and 
HOMA-IR, and WC with lipids. The differences in 
correlation coefficients between BMI and WC were 
minimal, and the authors concluded that the addition 
of WC measurement to BMI is of little benefit, and 
BMI alone would be enough to estimate cardiovascular 
risk in adolescents.
No association was found in our study between the 
adiposity indicators and total cholesterol, HDL and 
LDL, perhaps because the small number of participants 
may have limited these associations. This interdepen-
dence has been demonstrated in epidemiological stud-
ies in expressive samples (31). Another factor, which 
may have influenced the results in our study, was that 
analysis of food cholesterol intake had not been per-
formed.
Inflammatory markers along with the assessment 
of adiposity may contribute in identifying those with 
a higher cardiometabolic risk, in which case the thera-
peutic efforts should be more intensive. The CRP is 
a well-established marker of cardiovascular risk and 
studies in adults have shown the influence of obesity, 
especially central fat accumulation, as an important de-
terminant of this parameter (32). In the present study, 
CRP was associated mainly with TFM and BF% despite 
a minimal difference for the other indicators of adipos-
ity. Other authors have reported an association of CRP 
with BMI and the waist-hip ratio (33). CRP was also 
associated with insulin and HOMA-IR values, similar 
to that described in the literature (34) indicating that 
the analysis of this cardiovascular risk marker can help 
to detect individuals with a higher tendency for insulin 
resistance independently of adiposity.
TNF-α and IL-6 are pro-inflammatory cytokines 
related to a number of pathophysiological processes, 
including insulin resistance, energy homeostasis and 
body weight. Similarly to other reports (35,36), we did 
not find an association between TNF-α and IL-6 with 
the adiposity indicators. The production of these cyto-
kines is guided mainly by visceral adipose tissue, which 
is still scarce in the age group of our study cohort, and 
it is possible that this inflammatory process is still not 
present at this time (37). Also, studies in rodents show 
that triglycerides and free fatty acids exert influence on 
TNF-α production and recombinant HDL adminis-
tration has a reducing effect on the expression of this 
cytokine. This may explain the negative association of 
TNF-α with HDL found in our study (38,39).
Leptin presents a linear association with total body 
fat, especially with subcutaneous adipose tissue (40). In 
the present study, leptin concentration varied in equal 
proportion to TFM and BMI and was associated with 
all metabolic parameters related to increased adiposity 
(SBP, DBP, insulin and HOMA-IR).
Adiponectin, in turn, is associated more specifically 
with the visceral compartment and reduces proportion-
ately to central fat accumulation, acting as a risk marker 
for metabolic syndrome (41). In our study, however, adi-
ponectin was negatively associated with BMI and no as-
sociation was found with central adiposity measurements.
Glucose, insulin, HOMA-IR and triglycerides were 
negatively correlated with adiponectin, corroborat-
ing with authors who have reported that the presence 
of insulin resistance is associated with lower adiponec-
tin values and higher levels of triglycerides, intravisceral 
and intramyocellular fat (42). Adiponectin acts through 
intracellular pathways promoting activation of glucose 
transporters, fatty acid oxidation in muscle and inhibi-
tion of gluconeogenesis resulting in decreased blood glu-
cose and insulin levels. These mechanisms may explain 
our findings of lower adiponectin levels associated with 
higher levels of glucose, insulin and HOMA-IR (43).
Resistin was associated only with the BF% in our 
analysis, and its relationship with the distribution of fat, 
BMI and body fat mass is controversial in the litera-
ture (44). What is postulated is that circulating resistin 
levels tend to increase with age, probably reflecting an 
increase in body fat content as obese subjects tend to 
have higher resistin levels compared with lean subjects, 
but this process is not uniform and when resistin is el-
evated seems to produce a deleterious effect on angio-
genesis with increased cardiovascular risk.
This study has some limitations. The first is that it was 
done with a voluntary sample selected by convenience, 
which does not represent an unbiased population of this 
age group. Second, because the main study included an 
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interest in the adolescents who desired to lose weight, 
the proportion of participants who were overweight 
was higher than the prevalence of overweight and obe-
sity in the general population. Other limitations were 
the small number of participants and that there was no 
direct measurement of intra-abdominal fat, since fat lo-
cation may influence the inflammatory process of obe-
sity and the cytokines evaluated in this study.
In conclusion, all adiposity indicators studied dem-
onstrated a significant positive association with blood 
pressure, insulin, HOMA-IR, CRP and leptin. Triglyc-
erides were positively associated with BMI and WC, 
and adiponectin negatively associated in relation to 
BMI. IL-6, TNF-α, glucose, total cholesterol, HDL 
and LDL cholesterol were not associated with adipos-
ity indicators.
BMI was the adiposity indicator associated with 
most of the parameters studied, and it was characterized 
as an adequate tool to detect individuals in our study 
at risk for obesity complications. WC measurement was 
mainly correlated to the presence of insulin resistance, 
constituting a slightly better instrument for identifying 
individuals with this condition in this sample.
Few national studies have investigated adiposity in-
dicators compared with DXA, which is the gold stan-
dard method for measuring total and regional body fat. 
This study contributes relevant information to the un-
derstanding of obesity and its relation to metabolic pa-
rameters and inflammatory markers in the transitional 
period of adolescence.
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